Barclays Bank PLC has filed a new pricing supplement for the issuance of $924,000 in AutoCallable Contingent Coupon Notes linked to the American Depositary Shares of Arm Holdings plc. This issuance is significant as it showcases Barclays' ongoing strategy to diversify its financial products and respond to market demands.
The notes, which are set to mature on November 1, 2029, are designed to provide investors with contingent coupon payments based on the performance of the underlying reference asset, Arm Holdings. The initial valuation date for these notes was October 28, 2026, with the issue date scheduled for October 30, 2026.
Background
Barclays Bank PLC, incorporated in the United Kingdom, operates in the commercial banking sector, specifically categorized under SIC 6029 - Commercial Banks, NEC. The bank is known for its wide range of financial services, including investment banking, personal banking, and wealth management. Recent filings indicate that Barclays is actively engaging in various financial activities, with multiple filings on October 29, 2026, including this pricing supplement.
What the Filing Says
The pricing supplement, filed under accession number 0001918704-26-033298, details the terms and conditions of the AutoCallable Notes. The notes will have a minimum denomination of $1,000, and the contingent coupon payment is set at $44.125 per $1,000 principal amount note, contingent upon the performance of the reference asset.
Impact
This issuance may impact various stakeholders, including investors looking for structured financial products and competitors in the commercial banking sector. The notes are not guaranteed by any third party and are subject to the creditworthiness of Barclays Bank PLC, which adds a layer of risk for potential investors.
What's Next
Following this filing, Barclays Bank PLC may proceed with further disclosures or updates regarding the performance of these notes and any related financial products. The filing does not specify what happens next.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










